{"id":"W2884362356","doi":"10.1038/s41375-018-0210-1","title":"Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":247,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; National Institutes of Health; Servier; Astex Pharmaceuticals; Astellas Pharma; Gilead Sciences; Ablynx; Teva Pharmaceutical Industries; Sanofi; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer","keywords":"Medicine; Internal medicine; Tolerability; Gastroenterology; Peripheral edema; Nausea; Discontinuation; Adverse effect; Refractory (planetary science); Minimal residual disease; Progressive disease; Leukemia; Surgery; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001139817,0.0005591295,0.001062425,0.0002079628,0.0002377756,0.0005041857,0.0003874713,0.0004892533,0.0009999613],"category_scores_gemma":[0.0005016176,0.0001950577,0.0004969278,0.0001709883,0.0003447028,0.0004377181,0.0002044627,0.000955213,0.0002683206],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003293749,"about_ca_system_score_gemma":0.0004008072,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003478217,"about_ca_topic_score_gemma":0.001146332,"domain_scores_codex":[0.9997168,0.000169094,0.00001454366,0.00002742195,0.00002247835,0.00004956589],"domain_scores_gemma":[0.9997173,0.00007611295,0.00007365942,0.00002170539,0.00002170502,0.00008956613],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3322299,0.02816729,0.01847937,0.001677032,0.001185367,0.001042547,0.0007679805,0.003070589,0.2168382,0.0005241184,0.003819576,0.3921981],"study_design_scores_gemma":[0.187098,0.7414829,0.03642922,0.0001511254,0.0005994883,0.001582967,0.0002122773,0.002231724,0.02017952,0.0002098075,0.00978335,0.00003959646],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954534,0.003142081,0.000244164,0.0001297135,0.00003837967,0.0002977622,0.0001248323,0.00002382396,0.0005458593],"genre_scores_gemma":[0.9961495,0.002058273,0.0003602059,0.0001876375,0.00008086851,0.0002036661,0.0002881769,0.000008371887,0.0006633137],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001139817,"threshold_uncertainty_score":0.006027997,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009278922816624076,"score_gpt":0.2184857901486672,"score_spread":0.2092068673320432,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}